combining retatrutide and tirzepatide Weight loss with as compared to currently licenced obesity Retatrutide vs Tirzepatide: GLP-1, GIP

GHK-Cu as an anti-inflammatory agent Numerous studies have shown that GHK-Cu may reduce inflammation and free radical damage, repair protective skin barrier proteins, and improve the rate of healing following tissue injury [1]

An animal experiment on mice found that the mechanism of BN treating obesity is targeting the composition of major lipid classes and the expression of genes in lipid metabolism in adipose tissue to counteract high-fat diet-induced obesity (45)

- Common options: Glargine U100 (Lantus), Glargine U300 (Toujeo), and Degludec (Tresiba)

Tiredness with Zepbound may result from reduced caloric intake due to decreased appetite, dehydration and electrolyte imbalances from gastrointestinal side effects, or rapid weight loss